I don't think so. If you have read the previous 10QSB's you should known that they would need more capital if they are to execute as cash on hand is and has been an issue. This is a penny stock and is a risk hence the high risk/reward. If you work in the biotech/pharma industry you should know that a product like this is needed, if not by Cryoport by someone else. I still think Cryoport will succeed but I could be wrong. An interesting note from the 10QSB:
"The increase in inventories is due to the purchase of additional raw materials in June in order to fulfill a customer order shipped in July”
One more thing: they have been saying for a while that they haven't planned on selling the one way shipper until Q2 of fiscal 2008. This is coming up and will be the real test to see if they execute as they have planned. Also as I have been saying the up listing means nothing, all it does is allow for Cryoport to begin releasing news items like which biotech companies they have been working with, etc. Which imo is the more interesting news.
News 
Market Data 
Discover 
AI
